Pharmaceutical giant AstraZeneca has announced a bold commitment to fight against climate change and biodiversity loss. The company plans to invest $400 million in reforestation projects around the world, aiming to plant 200 million trees by 2030. This ambitious initiative is part of AstraZeneca's broader efforts to reduce its own carbon footprint and greenhouse emissions.
The investment will focus on reforestation projects in Brazil, India, Vietnam, Ghana, and Rwanda. By planting millions of trees in these countries, AstraZeneca aims to contribute to the restoration of vital ecosystems and mitigate the effects of deforestation. The company's ultimate goal is to achieve a 98% reduction in greenhouse emissions from its operations and fleet by 2026.
This announcement comes at a crucial time when the urgency to combat climate change is increasingly recognized. However, it is worth noting that AstraZeneca's $400 million commitment, while substantial, may still be a drop in the ocean considering the scale of the global challenge.
In other news, an independent advisory panel set up by the UK government has issued a warning that the country's chances of achieving its climate goals are becoming slimmer. The Climate Change Committee emphasizes that UK officials are moving too slowly in cutting greenhouse gas emissions, making it increasingly unlikely that the targets set for the end of this decade will be met.
To address concerns about price pressures on households, Chancellor of the Exchequer Jeremy Hunt is scheduled to meet with regulators of key UK industries. The government aims to ensure that cost reductions are being passed on to consumers and that interest rate rises are benefiting savers. Water, energy, and telecommunications watchdogs are expected to attend, along with the Competition and Markets Authority and the Financial Conduct Authority.
Moreover, in the financial sector, there is speculation about potential job cuts and reshuffling. UBS Group AG is reportedly planning to reduce more than half of Credit Suisse Group AG's workforce, causing uncertainty among bankers, traders, and support staff. This move comes as UBS seeks to streamline operations in London, New York, and certain parts of Asia.
Additionally, Odey Asset Management is in advanced talks to transfer four of its European equity funds, along with fund manager Oliver Kelton, to SW Mitchell Capital. This potential move follows a decline in investor confidence in Odey after allegations were made against its founder, Crispin Odey, regarding his treatment of women.
Looking ahead, online gifting firm Moonpig Group Plc is set to provide an update on its financial performance. Analysts forecast the company's full-year revenue to reach £320 million, compared to the £304 million reported in the previous fiscal year.